Trump claimed a win on drug prices, but Big Pharma also scored

In the two days since the announcement, the company’s stock jumped 14 percent as investors realized the new U.S. prices posed little threat to profits. It also allowed Pfizer to avoid import levies for three years. And because the Pfizer agreement is expected to serve as a model for other large drug...

Redirecting to full article...